Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 28:2021:6803510.
doi: 10.1155/2021/6803510. eCollection 2021.

Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro

Affiliations

Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro

Gang Wang et al. Dis Markers. .

Abstract

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most significant public health threat worldwide. Patients with severe COVID-19 usually have pneumonia concomitant with local inflammation and sometimes a cytokine storm. Specific components of the SARS-CoV-2 virus trigger lung inflammation, and recruitment of immune cells to the lungs exacerbates this process, although much remains unknown about the pathogenesis of COVID-19. Our study of lung type II pneumocyte cells (A549) demonstrated that ORF7, an open reading frame (ORF) in the genome of SARS-CoV-2, induced the production of CCL2, a chemokine that promotes the chemotaxis of monocytes, and decreased the expression of IL-8, a chemokine that recruits neutrophils. A549 cells also had an increased level of IL-6. The results of our chemotaxis Transwell assay suggested that ORF7 augmented monocyte infiltration and reduced the number of neutrophils. We conclude that the ORF7 of SARS-CoV-2 may have specific effects on the immunological changes in tissues after infection. These results suggest that the functions of other ORFs of SARS-CoV-2 should also be comprehensively examined.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Expression of ACE2 and distribution of ORF7 in A549 cells. (a) Expression of ACE2 in A549 cells (qRT-PCR). (b) Expression of ACE2 in A549 cells (Western blotting). (c) FLAG-ORF7 expression in A549-ORF7 cells (Western blotting). (d) Cellular distribution of ORF7 in A549-ORF7 cells (immunofluorescence microscopy).
Figure 2
Figure 2
Effect of ORF7 on the expression of cytokines and chemokines in A549 cells. (a) Relative to control cells, A549-ORF7 cells had increased expression of IL-6, CCL2, and IFN-β (all P < 0.01), decreased expression of IL-1α, IL-8, and TNF-α (all P < 0.01), but similar expression of IL-1β and IFN-α (both P > 0.05). CCL7 and IL-10 were undetectable (qRT-PCR). (b) Activation of innate immunity by SeV/VSV infection increased the expression of CCL2 and decreased the expression of IL-8 in A549-ORF7 cells compared to control cells (both P < 0.05; qRT-PCR). (c) A549-ORF7 cells had increased levels of CCL2 and decreased levels of IL-8 relative to control cells (both P < 0.01; ELISA).
Figure 3
Figure 3
Effect of ORF7 on chemotaxis of neutrophils and monocytes. (a–d) Neutrophils were identified as CD11b+ cells and monocytes as CD14+ positive cells (flow cytometry). (g–n) Chemotaxis of monocytes and neutrophils (upper chamber) in response to A549-ORF cells (lower chamber) was examined by staining (Transwell assay). (e, f) Quantitation of chemotaxis results showing increased monocyte chemotaxis and decreased neutrophil chemotaxis (both P < 0.01).

Similar articles

Cited by

References

    1. Zhou P., Yang X.-L., Wang X.-G., et al. Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature . 2020;588(7836):p. E6. doi: 10.1038/s41586-020-2951-z. - DOI - PMC - PubMed
    1. Bedford J., Enria D., Giesecke J., et al. COVID-19: towards controlling of a pandemic. Lancet . 2020;395(10229):1015–1018. doi: 10.1016/S0140-6736(20)30673-5. - DOI - PMC - PubMed
    1. Cao J., Tu W. J., Cheng W., et al. Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clinical Infectious Diseases . 2020;71(15):748–755. doi: 10.1093/cid/ciaa243. - DOI - PMC - PubMed
    1. Zhu Z., Lian X., Su X., Wu W., Marraro G. A., Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res . 2020;21(1):p. 224. doi: 10.1186/s12931-020-01479-w. - DOI - PMC - PubMed
    1. Christian M. D., Poutanen S. M., Loutfy M. R., Muller M. P., Low D. E. Severe acute respiratory syndrome. Clinical Infectious Diseases . 2004;38(10):1420–1427. doi: 10.1086/420743. - DOI - PMC - PubMed